SYRS stock plummets as late-stage cancer study of lead candidate fails to achieve its primary endpoint leading to the termination of the study.

Renamed newcomer will be positioned between the Sonet and Seltos and go on-sale in early 2025 in India with South African market availability unknown at present.

According to reports, the incident occurred around Thursday midnight. The vehicle, reportedly travelling at high speed, ...

Find out the latest Kia Syros car price, reviews, specifications, images, mileage, videos and more. Get expert reviews on the ...

The SELECT-MDS-1 trial showed no significant complete response rate improvement with tamibarotene plus azacitidine for ...

Kia has begun testing the next-generation version of its most popular product, the Seltos SUV. A test mule of the same was ...

That’s right. Kia has teased the upcoming crossover called the Syros. For now, the Korean manufacturer intends to offer it in ...

A new conviction was issued by the Mixed Jury Court for those responsible for the horrific death of Michalis Paschalakis, ...

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.

Orry steals the spotlight with his charming style at the Tira flagship store launch. New Delhi, Nov. 14 -- Orry steals the ...

PashminaRoshan effortlessly channels her inner Barbie doll at the Tira flagship store launch Nisha Madhulika: The teacher who ...

Even more impressive is the fact the JS8 PHEV can travel up to 84 km on pure electric power based on the WLTC cycle. With a ...